1
40
2
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
3–17; quiz 18
Issue
6
Volume
17
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
From mechanisms to management: translating the neuropathic pain consensus recommendations into clinical practice.
Publisher
An entity responsible for making the resource available
Journal of the American Academy of Nurse Practitioners
Date
A point or period of time associated with an event in the lifecycle of the resource
2005
2005-06
Subject
The topic of the resource
Adult; Female; Humans; Middle Aged; Aged; Chronic Disease; Inflammation; Risk Factors; Evidence-Based Medicine; Practice Guidelines as Topic; Patient Selection; Acute Disease; Analgesics/therapeutic use; Patient Education as Topic; *Pain/diagnosis/etiology/physiopathology; Anticonvulsants/therapeutic use; Nervous System Diseases/*complications; Nurse Practitioners; Pain Management; Anesthetics; Drug Therapy; Combination; Antidepressive Agents; Local/therapeutic use; Tricyclic/therapeutic use
Creator
An entity primarily responsible for making the resource
Chevlen Eric; Davis Pamela Stitzlein; Rhiner Michelle
Description
An account of the resource
Chronic neuropathic pain poses a treatment challenge, and is associated with significant psychologic distress, physical disability, and impaired functioning, which impact the activities of daily living. Efforts to provide relief are often inadequate and/or require polypharmacy. This has spurred interest among researchers and clinicians alike to develop early, intensive treatments that target the molecular and cellular mechanisms involved in pain transduction, transmission, and modulation, or ideally, that prevent neuropathic pain from occurring in the first place. Currently, researchers are attempting to capitalize on our understanding of neuropathic pain pathophysiology to develop drugs that interrupt distinct activities involved in its perpetuation. In this regard, several potential agents (eg, NMDA and AMPA/kainate antagonists) are in phase 2 and 3 clinical trials. In the interim, evolving data and evidence-based neuropathic treatment recommendations provide guidance for selecting first- and second-line medications that alone or in combination offer acceptable neuropathic pain control and allow clinicians to bridge the gap between current knowledge and its application in the clinical setting. Hopefully, as basic and clinical science progresses, further treatment advances and management tools will be found to improve the care of patients who live with neuropathic pain.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Pain/diagnosis/etiology/physiopathology
2005
Acute Disease
Adult
Aged
Analgesics/therapeutic use
Anesthetics
Anticonvulsants/therapeutic use
Antidepressive Agents
Chevlen Eric
Chronic Disease
Combination
Davis Pamela Stitzlein
Department of Internal Medicine
Drug Therapy
Evidence-Based Medicine
Female
Humans
Inflammation
Journal of the American Academy of Nurse Practitioners
Local/therapeutic use
Middle Aged
NEOMED College of Medicine
Nervous System Diseases/*complications
Nurse Practitioners
Pain Management
Patient Education as Topic
Patient Selection
Practice Guidelines as Topic
Rhiner Michelle
Risk Factors
Tricyclic/therapeutic use
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Pages
137–140
Issue
3
Volume
31
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Rhodotorula minuta: an unusual fungal infection in hip-joint prosthesis.
Publisher
An entity responsible for making the resource available
American journal of orthopedics (Belle Mead, N.J.)
Date
A point or period of time associated with an event in the lifecycle of the resource
2002
2002-03
Subject
The topic of the resource
Female; Humans; Aged; Antifungal Agents/therapeutic use; Anti-Infective Agents; *Mycoses/drug therapy; *Rhodotorula; Amphotericin B/therapeutic use; Bacitracin/therapeutic use; Hip Prosthesis/*adverse effects; Prosthesis-Related Infections/*microbiology; Drug Therapy; Combination; Local/therapeutic use
Creator
An entity primarily responsible for making the resource
Cutrona Anthony F; Shah Munir; Himes Melissa S; Miladore Michael A
Description
An account of the resource
Fungal infections of total joint arthroplasty are uncommon complications, and most cases have been associated with Candida species. In this article, we present a case in which a total hip arthroplasty was infected with Rhodotorula minuta. Intraoperative gram stain showed yeast formsand led to early detection and immediate treatment with amphotericin B and bacitracin. Successful reimplantation was performed 12 months later. To our knowledge, this is the first reported case of arthroplasty infection caused by R minuta.
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
*Mycoses/drug therapy
*Rhodotorula
2002
Aged
American journal of orthopedics (Belle Mead, N.J.)
Amphotericin B/therapeutic use
Anti-Infective Agents
Antifungal Agents/therapeutic use
Bacitracin/therapeutic use
Combination
Cutrona Anthony F
Department of Internal Medicine
Drug Therapy
Female
Himes Melissa S
Hip Prosthesis/*adverse effects
Humans
Local/therapeutic use
Miladore Michael A
NEOMED College of Medicine
Prosthesis-Related Infections/*microbiology
Shah Munir